•  
  •  
  •  
  •  

2025-10-06 15:57:13

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025

Keywords Selected:  INE864I01014

Stock Report

  • MTAR Technologies Ltd secures Rs. 386 Crs orders in Clean Energy - Fuel cells segment
  • MTAR Technologies Ltd enters into a 10 year long-term contract with Weatherford Products GMBH
  • MTAR Technologies Limited bags Rs. 34 Crs orders in Clean Energy and Aerospace sectors
  • MTAR bags Rs. 226 Crs of orders in Clean Energy and Aerospace segments
  • MTAR Technologies Ltd receives Rs. 15.4 Crs order
  • MTAR clocks a revenue of Rs. 580.8 Cr in FY 24
  • MTAR Technologies Ltd clocks a revenue of Rs. 118.4 Cr in Q3 FY 24
  • MTAR Technologies Ltd receives the Defence Industrial License for Production of Various Mechancial and Electronic Subsystems
  • Ratings by Dun & Bradstreet for ESG Practices of MTAR Technologies Limited
  • MTAR signs MoU with IN-SPACe India for Small Satellite Launch Vehicle
  • MTAR Technologies receives orders of $22.12 Mn in Clean Energy
  • MTAR Technologies to acquire 100% in GEE PEE Aerospace & Defence Pvt Ltd
  • MTAR gets approval from Board for acquisition of Gee Pee Aerospace & Defence Private Limited
  • MTAR declared Ll bidder for projects worth approximately Rs. 135 Cr in Civil Nuclear Power Sector
  • MTAR Technologies Ltd declares interim dividend of Rs. 3

Latest Post

  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024